drimanial: isolated from the bark of Drimys wintery (Winteraceae); structure in first source
Flora | Rank | Flora Definition | Family | Family Definition |
---|---|---|---|---|
Drimys | genus | A plant genus of the family WINTERACEAE. They have leathery, elliptic-shaped leaves; red-tinged shoots; and jasmine-scented, cream-colored, 8- to 12-petaled, 2.5-centimeter (1-inch) flowers in clusters.[MeSH] | Winteraceae | A plant family of the order Magnoliales, subclass Magnoliidae, class Magnoliopsida. The wood lacks water-conducting cells but has acrid sap. The leaves are gland-dotted, leathery, and smooth-margined. The flowers are small, in clusters, with two to six sepals, petals in two or more series, several stamens, and one to several carpels.[MeSH] |
ID Source | ID |
---|---|
PubMed CID | 636975 |
MeSH ID | M0443620 |
Synonym |
---|
inchi=1/c25h30o6/c1-23(2)13-12-21(24(3)20(16-27)18(15-26)11-14-25(23,24)29)31-22(28)10-7-17-5-8-19(30-4)9-6-17/h5-11,15-16,20-21,29h,12-14h2,1-4h3/b10-7+/t20-,21+,24-,25+/m0/s |
(1r,4ar,8r,8as)-7,8-diformyl-4a-hydroxy-4,4,8a-trimethyl-1,2,3,4,4a,5,8,8a-octahydronaphthalen-1-yl rel-(2e)-3-(4-methoxyphenyl)acrylate |
drimanial |
2-propenoic acid, 3-(4-methoxyphenyl)-, (1r,4ar,8r,8as)-7,8-diformyl-1,2,3,4,4a,5,8,8a-octahydro-4a-hydroxy-4,4,8a-trimethyl-1-naphthalenyl ester, (2e)- |
3-(4-methoxy-phenyl)-acrylic acid 7,8-diformyl-4a-hydroxy-4,4,8a-trimethyl-1,2,3,4,4a,5,8,8a-octahydro-naphthalen-1-yl ester |
[(1r,4ar,8r,8as)-7,8-diformyl-4a-hydroxy-4,4,8a-trimethyl-2,3,5,8-tetrahydro-1h-naphthalen-1-yl] (e)-3-(4-methoxyphenyl)prop-2-enoate |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |